In a recent announcement, President Trump emphasized his intention to end what he refers to as child sexual mutilation associated with various forms of gender-affirming care. Following his executive action, numerous hospitals and health systems across the country have discontinued these services for minors, which include surgeries and hormone therapies. Institutions like Yale New Haven Health and Phoenix Children’s Hospital have publicly declared their decision to halt these practices, reflecting a broader trend among healthcare facilities in response to the administration’s directive.

The decision to stop gender-affirming care for minors has prompted significant actions from several health systems throughout the United States. Major hospitals, such as Stanford Medicine and Children’s Hospital Los Angeles, have announced that they will no longer provide surgeries or hormone treatments to patients under the age of 19. This movement has gained momentum in various states, with multiple healthcare providers making similar announcements in Pennsylvania, New York, and California.

This development indicates a shift in healthcare policies concerning gender-affirming care for children and adolescents. The announcement highlights ongoing national debates regarding medical practices related to gender identity and the appropriate age for individuals to access such interventions. As the healthcare landscape evolves, the implications of these changes are likely to remain a topic of discussion among policymakers, medical professionals, and the public.

Original: article